Induction of Cross-Reacting Antibodies Against the COVID-19 by BCG Vaccination in the Mouse Model

It was reported that tuberculosis and BCG vaccination are potential tools for reducing the burden of COVID-19, mainly through the non-specific trained immunity. We have investigated whether BCG vaccination is able to induce cross-reacting antibodies against the SARS-CoV-2. We have tested the induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahali, Nadia, Bahloul, Chokri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362411/
https://www.ncbi.nlm.nih.gov/pubmed/35907089
http://dx.doi.org/10.1007/s00284-022-02971-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362411/
https://www.ncbi.nlm.nih.gov/pubmed/35907089
http://dx.doi.org/10.1007/s00284-022-02971-w

Ejemplares similares